Expert Commentary

Dr. Andrew M. Kaunitz on prescribing systemic HT to older women

OBG Manag. 2015 February;27(2)
By
Andrew M. Kaunitz, MD
Author and Disclosure Information

Prescribing systemic hormone therapy is common, but controversial. Dr. Kaunitz elaborates on specific dosing and tapering patients, as well as considers women at risk for osteoporosis

 

Recorded at the 2014 meeting of the North American Menopause Society

Recommended Reading

Try testosterone only in women with hypoactive sexual desire
MDedge ObGyn
Ospemifene’s effect more comprehensive than its FDA indication
MDedge ObGyn
2014 Update on osteoporosis
MDedge ObGyn
New use for old DXA scanners?
MDedge ObGyn
Osteoporosis medication use down in older women
MDedge ObGyn
Hormone therapy ‘timing hypothesis’ gains ground in ELITE
MDedge ObGyn
Hot flashes linked to increased hip fracture risk
MDedge ObGyn
Unnecessary hysterectomies still significant, Michigan data indicate
MDedge ObGyn
Short-term hormone replacement therapy upped ovarian cancer risk
MDedge ObGyn
Seven years of hot flashes common during, after menopause
MDedge ObGyn

Related Articles